WASHINGTON, DC – The U.S. Department of Justice has charged Indian chemical manufacturer Vasudha Pharma Chem Limited (VPC) ...
Tonix Pharma (TNXP) has submitted an NDA for its candidate TNX-102 SL for fibromyalgia, with a PDUFA date set for August 15, 2025. See why I'm on the sidelines.
As Robert F. Kennedy Jr. settles into his role as President Donald Trump’s health secretary, one major promise he’s made is ...
MM+M Agency 100 issue is nominated for Best Single Issue of a Tabloid/Newspaper/Magazine for a brand with revenue between $3 ...
New research from the University of Colorado Anschutz Medical Campus is the first to identify defects related to metabolism (how the body processes and uses energy) in lymphoblast cell lines (LCLs) ...
TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a leader in disinfection and decontamination solutions, today announced an OEM partnership with Pharma Biotech System Components LLC/Pharma ...
14h
Zacks Investment Research on MSN5 Top-Ranked Mid-Cap Stocks to Buy for a Stellar PortfolioWall Street is suffering from volatility in the first quarter of 2025. Out of the three large-cap indexes, the S&P 500 and ...
The PMCPA has dug into the industry’s LinkedIn activities once again. | The PMCPA has dug into the industry’s LinkedIn activities once again. AstraZeneca received the harshest censure in the latest ...
The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...
With the popular social media app once again at risk of going dark, there are best practices pharma brands can use on other ...
In this episode of The Top Line, sponsored by PatientPoint, Andrew Schultz, President of PatientPoint Precision, discusses ...
Resmetirom is a medication approved by the FDA to treat adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results